At DSM Pharmaceutical Products, development of your project is embraced at any
stage in the process. Whether you’re in Phase I, Phase II, Phase III or ready
to go commercial, we can help you move your project in and out of development.
Leveraging expertise in a variety of disciplines and at a variety of
manufacturing facilities, DSM Pharmaceutical Products can and will move your
project from concept to completion.
Through the use of Chiral
Technologies, we can bring to the surface what you need and when you need
it to complete the cycle of chiral production. These include enantio- and
diastereomerically pure chiral building blocks. We approach it in an
integrated manner in which a combination of proprietary technologies are use
alongside our single competencies including biocatalysis, homogeneous
catalysis and oxidation.
For our biopharmaceutical customers, our
Groningen, Netherlands manufacturing facility offers the scope and
infrastructure necessary to meet your needs. Whether you’re delivering
monoclonal antibodies or proteins, Groningen has the integrated approach to
biopharmaceutical production that guarantees a quality product.
We can further your development stream through a dedicated early phase
development team centralized under the unit of
Rescom®, which stands for responsive and committed, our customers
have at their disposal a proven team that is taking projects from pre-clinical
all the way through to commercial. Comprised of 40 researchers in
state-of-the-art laboratories, Rescom drives your project through the project
pipeline, whatever stage you’re in----preclinical, or stage III; whatever
class of company you are ---- virtual or large pharma.
